Progenity (PROG) Receives $44M in Warrant Proceeds, Strengthens its Liquidity Position

Go back to Progenity (PROG) Receives $44M in Warrant Proceeds, Strengthens its Liquidity Position

Progenity Strengthens its Liquidity Position

November 23, 2021 6:30 AM EST

Company received more than $44 million in warrant exercises since August 2021.

Current liquidity position provides runway to achieve critical research and development milestones through 2022.

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today provided an update on its strengthened liquidity position.

Over the last several months, we made great strides in optimizing our capital structure and bolstering our liquidity position, said Eric dEsparbes, Chief Financial Officer... More